The Ratio of the Maximum High Attenuation Area Dimension to the Maximum Tumor Dimension May Be an Index of the Presence of Lymph Node Metastasis in Lung.

Slides:

Advertisements

Similar presentations

Lung Adenocarcinoma with Ipsilateral Breast Metastasis: A Simple Coincidence? Hsu-Ching Huang, MD, Jen-Fan Hang, MD, Mei-Han Wu, MD, Teh-Ying Chou, MD,

Advertisements

A Hole in the Heart Journal of Thoracic Oncology

Kazuma Nagata, MD, Reiko Kaji, MD, Keisuke Tomii, MD

FDG PET-CT Aids in the Preoperative Assessment of Patients with Newly Diagnosed Thymic Epithelial Malignancies Marcelo F.K. Benveniste, MD, Cesar A.

PET/CT Fusion Scan in Lung Cancer: Current Recommendations and Innovations Cristina Gámez, MD, PhD, Rafael Rosell, MD, PhD, Alejandro Fernández, MD, PhD,

Hironori Yoshida, MD, Young Hak Kim, MD Journal of Thoracic Oncology

Mediastinal lymph node staging of non-small-cell lung cancer: A prospective comparison of computed tomography and positron emission tomography Walter.

Response to Osimertinib in Choroidal Metastases from EGFRmt T790M–Positive Non– Small Cell Lung Adenocarcinoma Filippo Gustavo Dall’Olio, MD, Celeste.

Sclerosing Pneumocytoma with Lymph Node Metastasis

David T. Cooke, MD, Dennis J. Zheng, Karen A. Peterson, NP, Royce F

MET-Mutated NSCLC with Major Response to Crizotinib

Resection of Mucinous Lung Adenocarcinoma Presenting with Intractable Bronchorrhea Motoshi Takao, MD, PhD, Takehiro Takagi, MD, Hitoshi Suzuki, MD, PhD,

The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients.

Zeynep Eroglu, MD, Jae Kim, MD, Sharon Wilczynski, MD, PhD, Warren A

Rapidly Progressive Diffuse Cystic Lesions as a Radiological Hallmark of Lung Adenocarcinoma Jian Zhang, MD, Yi-Lin Zhao, MD, Ming-Xiang Ye, MD, Gang.

KRAS Mutation Analysis Helps to Differentiate Between Pulmonary Metastasis from Colon Adenocarcinoma In Situ and Primary Lung Adenocarcinoma Taylor M.

Electronic Updates for JTO Readers

Rapid Response of Brain Metastasis to Crizotinib in a Patient with ALK Rearrangement– Positive Non–Small-Cell Lung Cancer Hiroyasu Kaneda, MD, PhD, Isamu.

Complete Response Achieved 1 Year after a Single Administration of Nivolumab in a Patient with Lung Adenocarcinoma with Negative Expression of PD-L1

The Moth-Eaten Lung Journal of Thoracic Oncology

Percutaneous Computed Tomography-Guided Coaxial Core Biopsy for Small Pulmonary Lesions with Ground-Glass Attenuation Chia-Hung Lu, MD, FRCR, Cheng-Hsiang.

Successful Crizotinib Retreatment after Crizotinib-Induced Interstitial Lung Disease Satoru Yanagisawa, MD, PhD, Akira Inoue, MD, PhD, Akira Koarai, MD,

Hironori Yoshida, MD, Young Hak Kim, MD Journal of Thoracic Oncology

Coexistence of the BRAF Mutation and EGFR Exon 20 Insertion in a Patient with Lung Adenocarcinoma Lih-Chyun Chang, MD, Kuan-Yu Chen, MD, PhD, Jin-Yuan.

Mediastinal Nodal Involvement in Patients with Clinical Stage I Non–Small-Cell Lung Cancer: Possibility of Rational Lymph Node Dissection Tomohiro Haruki,

Oncological Characteristics of Radiological Invasive Adenocarcinoma with Additional Ground-Glass Nodules on Initial Thin-Section Computed Tomography:

Atypical Pleuropulmonary Tuberculosis Mimicking a Malignant Disease

Lung Adenocarcinoma with Ipsilateral Breast Metastasis: A Simple Coincidence? Hsu-Ching Huang, MD, Jen-Fan Hang, MD, Mei-Han Wu, MD, Teh-Ying Chou, MD,

Nikolaas De Maeyer, MD, Walter De Wever, MD, PhD, Christophe M

A Patient with Mediastinal Mature Teratoma Presenting with Paraneoplastic Limbic Encephalitis Katsunobu Kawahara, MD, Michiyo Miyawaki, MD, Kentarou.

Effective Treatment with Icotinib in Primary Adenoid Cystic Carcinoma of the Lung with Liver Metastasis Zhengbo Song, MD, Wei Wu, MD, Yiping Zhang, MD

Intratumoral Lymphatic Vessel Involvement is an Invasive Indicator of Completely Resected Pathologic Stage I Non-small Cell Lung Cancer Masahiko Harada,

Transformation to SCLC after Treatment with the ALK Inhibitor Alectinib Shiro Fujita, MD, PhD, Katsuhiro Masago, MD, PhD, Nobuyuki Katakami, MD, PhD,

Journal of Thoracic Oncology

Management of Multiple Primary Lung Cancer in Patients with Centrally Located Early Cancer Lesions Jitsuo Usuda, MD, PhD, Shuji Ichinose, MD, PhD, Taichirou.

A Hole in the Heart Journal of Thoracic Oncology

Solitary Choriocarcinoma in the Lung

Do Complex Mutations of the Epidermal Growth Factor Receptor Gene Reflect Intratumoral Heterogeneity? Akito Hata, MD, Shiro Fujita, MD, PhD, Reiko Kaji,

Elderly Former Smoker with HRAS Mutant Non–Small-Cell Lung Cancer

Ineffectiveness of Crizotinib on Brain Metastases in Two Cases of Lung Adenocarcinoma with EML4-ALK Rearrangement Denis Maillet, MD, Isabelle Martel-Lafay,

Frequency of Lymph Node Metastasis According to the Size of Tumors in Resected Pulmonary Adenocarcinoma with a Size of 30 mm or Smaller Yangki Seok,

Nivolumab-Induced Acute Diabetes Mellitus and Hypophysitis in a Patient with Advanced Pulmonary Pleomorphic Carcinoma with a Prolonged Tumor Response

Four-Year Complete Remission in a Patient with Metastatic Epidermal Growth Factor Receptor–Mutated Lung Cancer Treated with Two Cycles of Erlotinib Brendan.

A Case of ALK-Rearranged Adenocarcinoma with Small Cell Carcinoma-Like Transformation and Resistance to Crizotinib Yoon Jin Cha, MD, PhD, Byoung Chul.

Elizabeth Cathcart-Rake, MD, Ariel Lopez-Chavez, MD, MS

Steve R. Siegal, MD, John G. Hunter, MD, James P. Dolan, MD, MCR

The Role of Surgery in the Management of Primary Thymic Mucosa-associated Lymphoid Tissue (MALT) Lymphoma Kimihiro Shimizu, MD, PhD, Izumi Takeyoshi,

Novel Epidermal Growth Factor Receptor Mutation-Specific Antibodies for Non-small Cell Lung Cancer: Immunohistochemistry as a Possible Screening Method.

Jennifer L. Dallas, MD, Michael A. Jantz, MD, Judith L

Combination Treatment Using an EGFR Tyrosine Kinase Inhibitor plus Platinum-Based Chemotherapy for a Patient with Transformed Small Cell Carcinoma and.

Navigating the lung for hidden treasure

A Systematic Review of Restaging After Induction Therapy for Stage IIIa Lung Cancer: Prediction of Pathologic Stage Sara de Cabanyes Candela, MD, Frank.

Matthew Reichert, MD, Eric S. Bensadoun, MD

Multiple Primary Cancers or Multiple Metastases, That Is the Question

Multiple Pulmonary Nodules in an Elderly Woman

Frequency and Prognostic Significance of Preoperatively Detected Enlarged Regional Lymph Nodes in Patients with Pathological Stage I Non-small Cell Lung.

It’s All in the “Swerve of the Curve”

Antiangiogenesis Induced Tumor Cavitation in Lung Cancer

Andreas Rimner, MD, Kenneth E. Rosenzweig, MD

Tetsuzo Tagawa, MD, Miyuki Takasu, MD, Teruyoshi Ishida, MD

Metastatic Lung Cancer to the Pancreas

Follow-Up of Small (4 mm or Less) Incidentally Detected Nodules by Computed Tomography in Oncology Patients: A Retrospective Review Reginald F. Munden,

Intrathoracic Desmoid Tumor: Brief Report and Review of Literature

Cristiano Rampinelli, MD, Vittoria Vecchi, MD, Massimo Bellomi, MD

Journal of Thoracic Oncology

A clinicopathological study of resected adenocarcinoma 2 cm or less in diameter Norihiko Ikeda, MD, PhD, Junichi Maeda, MD, Koichi Yashima, MD, Masahiro.

Lack of FDG Uptake in Small Cell Carcinoma Associated with ANNA-1 Positive Paraneoplastic Autonomic Neuropathy Matthew S. Block, MD, PhD, Robert Vassallo,

Photodynamic Therapy (PDT) for Lung Cancers

Patterns-of-Care for Thoracic Stereotactic Body Radiotherapy among Practicing Radiation Oncologists in the United States Megan E. Daly, MD, Julian R.

Robert Comis, MD, The Passing of a “Lung Man”

Presentation transcript:

The Ratio of the Maximum High Attenuation Area Dimension to the Maximum Tumor Dimension May Be an Index of the Presence of Lymph Node Metastasis in Lung Adenocarcinomas 3 cm or Smaller on High-Resolution Computed Tomography Ryota Nishio, MD, Soichi Akata, Kazuhiro Saito, Tatsuo Ohira, Masahiro Tsuboi, Takashi Hirano, Norihiko Ikeda, Fumio Kotake, Harubumi Kato, Kimihiko Abe Journal of Thoracic Oncology Volume 2, Issue 1, Pages 29-33 (January 2007) DOI: 10.1016/S1556-0864(15)30014-9 Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 1 Measurement of tumor dimension and high-attenuation area. H/T ratio, ratio of the maximum dimension of the intratumor high-attenuation area (H) to the maximum dimension of the tumor (T). Journal of Thoracic Oncology 2007 2, 29-33DOI: (10.1016/S1556-0864(15)30014-9) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 2 Case 1. True negative: An 81-year-old woman. High-resolution computed tomography scan of the right upper lobe shows a nodule with a maximum dimension of 19 mm with no high-attenuation area (H/T ratio = 0%). The absence of lymph node metastasis (N0) was confirmed pathologically. H/T ratio, ratio of the maximum dimension of the intratumor high- attenuation area (H) to the maximum dimension of the tumor (T). Journal of Thoracic Oncology 2007 2, 29-33DOI: (10.1016/S1556-0864(15)30014-9) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 3 Case 2. True negative: A 73-year-old woman. High-resolution computed tomography scan of the right upper lobe shows a nodule with a maximum dimension of 26 mm and a 15-mm high-attenuation area (H/T ratio = 57.6%). The absence of lymph node metastasis (N0) was confirmed pathologically. H/T ratio, ratio of the maximum dimension of the intratumor high-attenuation area (H) to the maximum dimension of the tumor (T). Journal of Thoracic Oncology 2007 2, 29-33DOI: (10.1016/S1556-0864(15)30014-9) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 4 Case 3. True positive: A 62-year-old man. High-resolution computed tomography scan of the left upper lobe shows a nodule with a maximum dimension of 16 mm and a 15-mm high-attenuation area (H/T ratio = 93.8%). Ipsilateral hilar lymph node metastases (N1) were confirmed pathologically. H/T ratio, ratio of the maximum dimension of the intratumor high-attenuation area (H) to the maximum dimension of the tumor (T). Journal of Thoracic Oncology 2007 2, 29-33DOI: (10.1016/S1556-0864(15)30014-9) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 5 Case 4. False positive: A 52-year-old man. High-resolution computed tomography scan of the right upper lobe shows a nodule with a maximum dimension of 24 mm and a 17-mm high-attenuation area (H/T ratio = 70.3%). The H/T ratio exceeded 60%, but there was no lymph node metastasis (N0). H/T ratio, ratio of the maximum dimension of the intratumor high-attenuation area (H) to the maximum dimension of the tumor (T). Journal of Thoracic Oncology 2007 2, 29-33DOI: (10.1016/S1556-0864(15)30014-9) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 6 Case 5. True positive: A 71-year-old man. High-resolution computed tomography scan of the right upper lobe shows a nodule with a maximum dimension of 6 mm and a 6-mm high-attenuation area (H/T ratio = 100%). Even though it was a small tumor of only 6 mm, ipsilateral hilar lymph node metastasis metastases (N1) were confirmed pathologically. H/T ratio, ratio of the maximum dimension of the intratumor high-attenuation area (H) to the maximum dimension of the tumor (T). Journal of Thoracic Oncology 2007 2, 29-33DOI: (10.1016/S1556-0864(15)30014-9) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions